Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release

被引:191
作者
Neeli, Indira [1 ]
Radic, Marko [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA
关键词
NETosis; PAD4; protein kinase C; deimination; inflammation; PROTEIN-KINASE-C; NADPH OXIDASE; CELL-DEATH; ACTIVATION; TRAPS; PAD4; IMMUNITY; ADHESION; PHOSPHORYLATION; MYELOPEROXIDASE;
D O I
10.3389/fimmu.2013.00038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In response to inflammation, neutrophils deiminate histones and externalize chromatin. Neutrophil extracellular traps (NETs) are an innate immune defense mechanism, yet NETs also may aggravate chronic inflammatory and autoimmune disorders. Activation of peptidylarginine deiminase 4 (PAD4) is associated with NET release (NETosis) but the precise mechanisms of PAD4 regulation are unknown. We observed that, in human neutrophils, calcium ionophore induced histone deimination, whereas phorbol myristate acetate (PMA), an activator of protein kinase C (PKC), suppressed ionophore-induced deimination. Conversely, low doses of chelerythrine and sanguinarine, two inhibitors of PKC, reversed PMA inhibition and enhanced ionophore-stimulated deimination. In addition, a peptide inhibitor of PKC alpha superinduced ionophore activation of PAD4, thus identifying PK alpha as the PMA-induced inhibitor of PAD4. At higher doses, chelerythrine, sanguinarine, and structurally unrelated PKC inhibitors blocked histone deimination, suggesting that a different PKC isoform activates histone deimination. We identify PKC zeta as activator of PAD4 because a specific peptide inhibitor of this PKC isoform suppressed histone deimination. Confocal microscopy confirmed that, in the presence of PMA, NETosis proceeds without detectable histone deimination, and that ionophore cooperates with PMA to induce more extensive NET release. Broad inhibition of PKC by chelerythrine or specific inhibition of PKC zeta suppressed NETosis. Our observations thus reveal an intricate antagonism between PKC isoforms in the regulation of histone deimination, identify a dominant role for PK alpha in the repression of histone deimination, and assign essential functions to PKC zeta in the activation of PAD4 and the execution of NETosis. The precise balance between opposing PKC isoforms in the regulation of NETosis affirms the idea that NET release underlies specific and vitally important evolutionary selection pressures.
引用
收藏
页数:9
相关论文
共 48 条
[31]   THE PHARMACOLOGICAL ACTION OF CHELERYTHRINE [J].
POWELL, CE ;
CHEN, KK .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1955, 44 (04) :196-199
[32]   Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox [J].
Raad, Houssam ;
Paclet, Marie-Helene ;
Boussetta, Tarek ;
Kroviarski, Yolande ;
Morel, Francoise ;
Quinn, Mark T. ;
Gougerot-Pocidalo, Marie-Anne ;
Dang, Pham My-Chan ;
El-Benna, Jamel .
FASEB JOURNAL, 2009, 23 (04) :1011-1022
[33]   Activation of PAD4 in NET formation [J].
Rohrbach, Amanda S. ;
Slade, Daniel J. ;
Thompson, Paul R. ;
Mowen, Kerri A. .
FRONTIERS IN IMMUNOLOGY, 2012, 3
[34]   A novel protein kinase C α-dependent signal to ERK1/2 activated by αVβ3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells [J].
Rucci, N ;
DiGiacinto, C ;
Orrù, L ;
Millimaggi, D ;
Baron, R ;
Teti, A .
JOURNAL OF CELL SCIENCE, 2005, 118 (15) :3263-3275
[35]  
SCHENCK G., 1954, ARCH PHARM U BER DEUTSCH PHARM GES, V287, P544, DOI 10.1002/ardp.19542870912
[36]  
Steinberg BE., 2007, SCI STKE, V2007, pp, DOI [10.1126/stke.3792007pe11, DOI 10.1126/STKE.3792007PE11]
[37]   Structural basis of protein kinase C isoform function [J].
Steinberg, Susan F. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (04) :1341-1378
[38]   Phorbol 12-myristate 13-acetate induced cell death of porcine peripheral blood polymorphonuclear leucocytes [J].
Suzuki, K ;
Namiki, H .
CELL STRUCTURE AND FUNCTION, 1998, 23 (06) :367-372
[39]   Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis [J].
Takei, H ;
Araki, A ;
Watanabe, H ;
Ichinose, A ;
Sendo, F .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (02) :229-240
[40]  
TAUBER AI, 1987, BLOOD, V69, P711